Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 34.02 | N/A |
PEG Ratio (TTM) | -2.30 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 5.21 | N/A |
P/FCF Ratio (TTM) | -73.39 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | 11.43% | N/A |
ROE (TTM) | 4.82% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 186.33% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 101.06% | N/A | N/A |
Cash Flow | -149.08% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.06 | N/A |
Quick Ratio (TTM) | 0.06 | N/A |
D/E Ratio (TTM) | 0.13 | N/A |
Interest Coverage (TTM) | -2.02 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 8.15 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |